Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) EV-to-FCF: (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Singapore Institute Of Advanced Medicine Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Singapore Institute Of Advanced Medicine Holdings's Enterprise Value is S$107.86 Mil. Singapore Institute Of Advanced Medicine Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was S$0.00 Mil. Therefore, Singapore Institute Of Advanced Medicine Holdings's EV-to-FCF for today is .

The historical rank and industry rank for Singapore Institute Of Advanced Medicine Holdings's EV-to-FCF or its related term are showing as below:

SGX:9G2' s EV-to-FCF Range Over the Past 10 Years
Min: -9.83   Med: 0   Max: 0
Current: -9.83
SGX:9G2's EV-to-FCF is ranked worse than
100% of 409 companies
in the Healthcare Providers & Services industry
Industry Median: 18.66 vs SGX:9G2: -9.83

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-18), Singapore Institute Of Advanced Medicine Holdings's stock price is S$0.03. Singapore Institute Of Advanced Medicine Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was S$-0.011. Therefore, Singapore Institute Of Advanced Medicine Holdings's PE Ratio (TTM) for today is At Loss.

Singapore Institute Of Advanced Medicine Holdings  (SGX:9G2) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Singapore Institute Of Advanced Medicine Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.03/-0.011
=At Loss

Singapore Institute Of Advanced Medicine Holdings's share price for today is S$0.03.
Singapore Institute Of Advanced Medicine Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was S$-0.011.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Singapore Institute Of Advanced Medicine Holdings EV-to-FCF Related Terms

Singapore Institute Of Advanced Medicine Holdings EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Singapore Institute Of Advanced Medicine Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singapore Institute Of Advanced Medicine Holdings EV-to-FCF Chart

Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
EV-to-FCF
0.00 0.00 0.00 -11.05 -7.98

Singapore Institute Of Advanced Medicine Holdings Quarterly Data
Jun21 Jun22 Jun23 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -7.98 0.00 0.00

SGX:9G2 vs HCA, THC, DVA: EV-to-FCF Comparison

For the Medical Care Facilities subindustry, Singapore Institute Of Advanced Medicine Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Singapore Institute Of Advanced Medicine Holdings EV-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore Institute Of Advanced Medicine Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Singapore Institute Of Advanced Medicine Holdings's EV-to-FCF falls into.


Singapore Institute Of Advanced Medicine Holdings EV-to-FCF Calculation

Singapore Institute Of Advanced Medicine Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=107.858/0
=

Singapore Institute Of Advanced Medicine Holdings's current Enterprise Value is S$107.86 Mil.
Singapore Institute Of Advanced Medicine Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was S$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singapore Institute Of Advanced Medicine Holdings Business Description

Address 1 Biopolis Drive, No. 02-01 Amnios, Singapore, SGP, 138622
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.